Vol.

No.

September 05, 2025Sep 05, 2025

DOWNLOAD THE PDF

Cover Story

Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing

On Sept. 4, Jay Bhattacharya did something NIH directors rarely do: he appeared before the National Cancer Advisory Board, speaking directly with the NCI advisory board about hot-button policy changes taking place under his leadership at NIH.

Capitol Hill

House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99M
House joins Senate in rejecting Trump’s proposed 40% NIH cuts

By Jacquelyn Cobb and Paul Goldberg

NCI Director's Report

Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost

By Jacquelyn Cobb

Capitol Hill

With CDC in free fall, RFK Jr. faces bipartisan rebuke at Senate hearing
Kennedy calls CDC “the most corrupt agency at HHS and maybe the government.”

By Claire Marie Porter

Guest Editorial

Curing cancer or curbing immigration: A question of national morality and priority

By Paul W. Thurman

Conversation with The Cancer Letter Free Podcast

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

By Paul Goldberg and Sara Willa Ernst

City of Hope deploys HopeLLM: AI platform transforms clinical workflows and patient care

By Vijay Trisal

Free In the Archives

Rainer Storb: Six decades of bone marrow transplant breakthroughs
“His CV has more pages than almost any of you have papers.”

Cancer Policy

The departure (and return) of Vinay Prasad

Trump administration wants to rebuild stockpile of APIs to address drug shortages

Trump administration unlawfully terminated grants from Harvard, federal judge rules

FDA will speed up public release of Complete Response Letters

In Brief

John Byrd named director of UPMC Hillman Cancer Center

Richard Schilsky leaves role as PI of ASCO’s TAPUR study

CancerLinQ receives ASCO-certified RQS status

Catheryn Yashar named president-elect of ASTRO

Motaz Qadan named surgeon-in-chief at Mass General Brigham Cancer Institute

Alice Shaw named chair of Department of Medical Oncology at Dana-Farber

Weizhou Zhang named co-leader of Mechanisms of Oncogenesis research program at UF Health

Julie Bauman named deputy chair of NRG Oncology’s NCORP research program, Ryan Burri named vice chair of Veteran Affairs research

Kai Tsao appointed system chief of solid tumor oncology at Northwell

Laura Pinheiro appointed to co-lead COE at the Sandra and Edward Meyer Cancer Center at Weill Cornell

UC San Diego awarded $80M to expand clinical trials and train future researchers

Intermountain Health TeleOncology partnership expands cancer care to interior Alaska

Funding Opportunities

American Lung Association invites applications for grants to transform lung health

Clinical Roundup

City of Hope study shows childhood cancer survivors face new health problems later in life

MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

CAR T-cell therapy clinical trial debuts at KU Cancer Center

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows

Many patients with advanced cancer feel treatment not aligned with personal care goals, UC study shows

IO Biotech’s vaccine misses on mPFS in phase III advanced melanoma trial

Drugs & Targets

FDA approves expanded indication for Avtozma intravenous formulation in cytokine release syndrome

FDA grants breakthrough designation for Rina-S in advanced endometrial cancer

EC grants approval of Ogsiveo in desmoid tumors

ColoAlert colorectal screening test receives approval in Switzerland

NCI Trials

NCI Trials for September 2025

The National Cancer Institute approved the following clinical research studies last month.

CURRENT ISSUE

Recent Issues

Volume 51 | Issue 32 - September 05, 2025